US Broker Ratings

Verastem, Inc. (VSTM) Stock Analysis: Exploring a Potential 145.90% Upside in Biotech Innovation

Investors with a keen eye on the biotechnology sector may find Verastem, Inc. (VSTM) an intriguing prospect. This development-stage biopharmaceutical company, headquartered in Needham, Massachusetts, is..

Fulgent Genetics, Inc. (FLGT): Investor Outlook Amidst Challenging Valuation Metrics

Fulgent Genetics, Inc. (NASDAQ: FLGT), a notable player in the healthcare sector specializing in diagnostics and research, has been garnering attention for its innovative clinical diagnostic..

OrthoPediatrics Corp. (KIDS) Stock Analysis: 24% Potential Upside Amid Strong Buy Ratings

OrthoPediatrics Corp. (NASDAQ: KIDS), a key player in the medical device industry focused on pediatric orthopedics, is attracting significant attention from investors. With a robust market..

EyePoint, Inc. (EYPT) Stock Analysis: Exploring a 214.93% Potential Upside in the Biotech Sector

EyePoint, Inc. (NASDAQ: EYPT) is making waves in the healthcare sector, particularly within the biotechnology industry, thanks to its innovative approach to treating serious retinal diseases...

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a Robust 11.67% Potential Upside

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is capturing investor attention with its promising growth trajectory in the healthcare sector. Specializing in the development and commercialization of treatments..

Replimune Group, Inc. (REPL) Investor Outlook: Potential Upside of 97.17% Amidst Promising Biotech Innovations

Replimune Group, Inc. (NASDAQ: REPL), a burgeoning entity in the biotechnology sector, is capturing the attention of investors with its innovative approach to cancer treatment and..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring the 86.76% Potential Upside

For investors navigating the volatile waters of the cannabis industry, Tilray Brands, Inc. (NASDAQ: TLRY) presents a compelling case with its promising potential upside. Despite the..

Celcuity Inc. (CELC) Investor Outlook: Analyzing the 86.61% Potential Upside in Biotech Innovation

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its innovative approach to cancer treatment. Specializing in the..

Cross Country Healthcare, Inc. (CCRN) Investor Outlook: Navigating Market Challenges with Strategic Positioning

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a prominent player in the U.S. healthcare staffing industry, presents a complex investment profile amidst a challenging market environment. With..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring an 858% Potential Upside in the Biotech Sector

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is making waves in the biotechnology sector with its innovative approaches to treating diseases with unmet medical needs, such as Duchenne..

PureTech Health plc (PRTC) Stock Analysis: Navigating Challenges in the Biotech Landscape

PureTech Health plc (NASDAQ: PRTC) is a dynamic player in the biotechnology sector, focusing on innovative solutions to tackle complex health issues. Based in the United..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 163% Upside with Strategic Innovations

Sana Biotechnology, Inc. (NASDAQ: SANA) is garnering attention in the biotechnology sector with its innovative approach to engineered cell therapies and a significant potential upside of..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Robust Revenue Growth Amidst Challenges

Sonida Senior Living, Inc. (NASDAQ: SNDA) has been a focal point for investors in the healthcare sector, particularly those interested in the medical care facilities industry...

AbCellera Biologics Inc. (ABCL) Stock Analysis: Unveiling an 84.53% Potential Upside for Investors

AbCellera Biologics Inc. (NASDAQ: ABCL), headquartered in Vancouver, Canada, is making waves in the biotechnology industry with its innovative approach to antibody-based medicine discovery and development...

Ginkgo Bioworks Holdings, Inc. (DNA): Investor Outlook Amidst Challenging Metrics and Growth Potential

Ginkgo Bioworks Holdings, Inc. (DNA), a biotechnology company specializing in cell engineering and biosecurity, is navigating a complex landscape marked by both challenges and opportunities. Headquartered..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Unpacking a 22% Potential Upside in the Healthcare Sector

Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the healthcare sector focusing on regenerative medicine, offers a compelling opportunity for investors with a potential upside..

Beta Bionics, Inc. (BBNX) Investor Outlook: A 40.73% Potential Upside in the Medical Device Sector

For investors seeking exposure in the healthcare sector, particularly in medical devices, Beta Bionics, Inc. (NASDAQ: BBNX) presents an intriguing opportunity. With its market cap at..

Altimmune, Inc. (ALT) Stock Analysis: A Biotech Bet with 477.93% Potential Upside

Altimmune, Inc. (NASDAQ: ALT), a prominent player in the biotechnology sector, is capturing investor attention with its high upside potential and compelling analyst ratings. Headquartered in..

Cogent Biosciences (COGT) Stock Analysis: A Biotech with Promising Upside and Analyst Confidence

Cogent Biosciences, Inc. (NASDAQ: COGT) is capturing investor attention in the biotechnology sector with a strong market presence and compelling growth potential. As a clinical-stage biotech..

Zenas BioPharma, Inc. (ZBIO)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds